Who
Alexander J. Denner
Director
Company insider
Files Form 4 as: Director and 10% owner, Ironwood Pharmaceuticals; 10% owner, Innoviva; Director, Biogen; 10% owner, Sarissa Capital Acquisition; Director, Medicines Co /de; Director, Bioverativ; Director, Ariad Pharmaceuticals; Director, Vivus.
In numbers
- Trades disclosed
- 200
- Buys
- 47
- Sells
- 9
- Bought
- $333.2M
- Sold
- $80.4M
- Companies
- 12
- Companies where not an officer
- 12
- First trade
- 2 May 2006
- Last trade
- 15 Sep 2026
- Last filed
- 17 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2026filed 17 Sep 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —3,694 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —3,694 at $0.00 | filing |
| 16 Jun 2026filed 17 Jun 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —63,481 at $0.00 | filing |
| 16 Jun 2026filed 17 Jun 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —63,481 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,065 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,065 at $0.00 | filing |
| 17 Mar 2026filed 17 Mar 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $20.5M6,725,000 at $3.05 | filing |
| 17 Mar 2026filed 17 Mar 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $19K5,800 at $3.31 | filing |
| 17 Mar 2026filed 17 Mar 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $20.5M6,725,000 at $3.05 | filing |
| 17 Mar 2026filed 17 Mar 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $19K5,800 at $3.31 | filing |
| 13 Mar 2026filed 17 Mar 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,451 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,451 at $0.00 | filing |
| 15 Dec 2025filed 17 Dec 2025 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,178 at $0.00 | filing |
| 15 Sep 2025filed 17 Sep 2025 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —11,718 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 6 Mar 2025filed 6 Mar 2025 | INVA InnovivaPharmaceuticals | SEC FORM 4 Sold | $21.0M1,196,746 at $17.52 | filing |
| 5 Mar 2025filed 6 Mar 2025 | INVA InnovivaPharmaceuticals | SEC FORM 4 Sold | $4.8M270,374 at $17.63 | filing |
| 4 Mar 2025filed 6 Mar 2025 | INVA InnovivaPharmaceuticals | SEC FORM 4 Sold | $2.7M151,175 at $17.63 | filing |
| 18 Jun 2024filed 21 Jun 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —24,311 at $0.00 | filing |
| 15 Mar 2024filed 19 Mar 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,662 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.